PubRank

Gianfranco Pancino

Author PubWeight™ 66.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013 6.14
2 HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A 2007 4.96
3 The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol 2009 2.57
4 Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 2009 2.33
5 Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol 2009 2.17
6 Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 2003 1.96
7 Human TRIM gene expression in response to interferons. PLoS One 2009 1.84
8 Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007 1.72
9 Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006 1.64
10 Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 2011 1.62
11 HIV controllers: how do they tame the virus? Trends Immunol 2007 1.61
12 Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 2007 1.53
13 Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010 1.33
14 p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway. Proc Natl Acad Sci U S A 2013 1.31
15 Macrophages and HIV-1: dangerous liaisons. Mol Immunol 2005 1.31
16 The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J Virol 2009 1.30
17 Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients. AIDS 2014 1.28
18 Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007 1.27
19 Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc 2010 1.25
20 The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages. J Immunol 2006 1.00
21 Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 2003 1.00
22 HIV controllers: a genetically determined or inducible phenotype? Immunol Rev 2013 0.98
23 Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 2006 0.97
24 The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One 2008 0.97
25 Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 2003 0.97
26 Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood 2012 0.96
27 Quantitative real-time analysis of HIV-1 gene expression dynamics in single living primary cells. Biotechnol J 2006 0.96
28 Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic. AIDS Res Hum Retroviruses 2003 0.93
29 Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers. J Virol 2013 0.93
30 CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS 2003 0.92
31 Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks. Retrovirology 2006 0.91
32 Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses 2006 0.91
33 Lymphoid activation: a confounding factor in AIDS vaccine development? J Gen Virol 2002 0.86
34 HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J Acquir Immune Defic Syndr 2006 0.86
35 New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia. AIDS 2004 0.86
36 First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections". Retrovirology 2005 0.85
37 CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection. PLoS One 2013 0.84
38 Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages. Virology 2009 0.83
39 The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PLoS One 2011 0.82
40 Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts. PLoS One 2010 0.81
41 Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes. J Allergy Clin Immunol 2012 0.78
42 Will it be possible to live without antiretroviral therapy? Curr Opin HIV AIDS 2013 0.78
43 The MHC-haplotype influences primary, but not memory, immune responses to an immunodominant peptide containing T- and B-cell epitopes of the caprine arthritis encephalitis virus Gag protein. Vaccine 2005 0.78
44 Efavirenz in plasma from HIV-infected patients does not directly block reverse transcriptase activity in cell-free assays but inhibits HIV replication in cellular assays. AIDS Res Hum Retroviruses 2006 0.77
45 Reply to Pauls et al.: p21 is a master regulator of HIV replication in macrophages through dNTP synthesis block. Proc Natl Acad Sci U S A 2014 0.77
46 Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population. J Acquir Immune Defic Syndr 2005 0.75